# Menopur Mixed Protocol

> **NCT01417195** · PHASE4 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 122 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Bravelle
- **DRUG:** Menopur

## Key facts

- **NCT ID:** NCT01417195
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2014-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01417195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01417195, "Menopur Mixed Protocol". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT01417195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*